Heron Therapeutics (HRTX) Interest Coverage Ratio (2012 - 2017)

Heron Therapeutics (HRTX) has reported Interest Coverage Ratio for 6 consecutive years, with 47.86 the latest figure, recorded in Q1 2017.

• For the quarter ending Q1 2017, Interest Coverage Ratio rose 80.89% year-over-year to 47.86; the trailing twelve-month figure through Mar 2017 stood at 54.28 (up 57.56% YoY), and the FY2025 full-year result was 0.26, up 86.17% from the prior year.
• Interest Coverage Ratio retreated to 47.86 in Q1 2017 per HRTX's latest filing, from 36.85 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 36.85 in Q4 2016 and bottomed at 250.47 in Q1 2016.
• Historically, Interest Coverage Ratio has averaged 91.75 across 5 years, with a median of 84.61 in 2014.
• The sharpest annual moves came in 2016 and 2017: Interest Coverage Ratio plunged 185.4% in 2016, then soared 80.89% in 2017.
• Over 5 years, Interest Coverage Ratio stood at 65.24 in 2013, then plunged by 31.64% to 85.88 in 2014, then tumbled by 46.42% to 125.75 in 2015, then soared by 70.69% to 36.85 in 2016, then declined by 29.88% to 47.86 in 2017.
• According to Business Quant data, Interest Coverage Ratio over the past three periods registered 47.86, 36.85, and 53.88 for Q1 2017, Q4 2016, and Q3 2016 respectively.